Pharmacists can reduce COVID-19 vaccine hesitancy through honest, nonjudgmental communication and by using every patient touchpoint as an opportunity to offer vaccination.
|Videos|December 17, 2020
Health Workers Lead the Charge, Receiving First COVID-19 Vaccines in Rochester, New York
Pharmacists, physicians, and nurses have been among the first to receive COVID-19 vaccinations at health care facilities across the country.
Advertisement
As health facilities around the country begin receiving Pfizer’s coronavirus disease 2019 (COVID-19) vaccine, pharmacists, physicians, and nurses have been among the first to receive vaccinations. At Strong Memorial Hospital in Rochester, New York, employees received the vaccine and spoke about why they believe it is important to get vaccinated.
Advertisement
Related to this article
October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial.
October’s hematology coverage highlighted first-line pirtobrutinib, questions about myeloma treatment duration and early intervention, and pharmacists’ roles in medication safety and access.
October’s oncology coverage highlighted new treatment options in rectal, breast, and prostate cancers, alongside longer-term survival findings and concerns about reduced-frequency immunotherapy.
Young adults who vaped daily but never smoked had lower flow-mediated dilation and peak oxygen uptake than peers who used neither product.
ESMO 2026 lung cancer trials reshape first-line care with tarlatamab maintenance, stronger KRAS G12C results, and TROP2 ADC gains, raising pharmacy monitoring demands.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cystatin C and the Future of Kidney Function Assessment
2
COVID-19 ‘Is Not Done With Us’: Pharmacist Urges Continued Vaccination Ahead of Seasonal Peaks
3
October 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
4
Tarlatamab and Next-Generation Targeted Agents Headline ESMO 2026 Lung Cancer Data
5